MLSS — Milestone Scientific Cashflow Statement
0.000.00%
Last trade - 00:00- $24.69m
- $24.20m
- $8.63m
Annual cashflow statement for Milestone Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.39 | -6.88 | -8.77 | -6.98 | -4.71 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2.12 | 1.85 | 3.23 | 2.99 | 2.39 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.81 | 0.922 | -0.55 | -1.4 | -0.631 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -6.98 | -4.03 | -6.03 | -5.33 | -2.92 |
| Capital Expenditures | -0.021 | -0.015 | -0.009 | -0.005 | -0.01 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -2.97 | 2.98 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.021 | -0.015 | -0.009 | -2.97 | 2.97 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 19.7 | 4.59 | -0.009 | 2.56 | 0.234 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.7 | 0.54 | -6.05 | -5.74 | 0.28 |